BPC 157 Dosage by Goal Not everyone runs BPC 157 for the same reason
Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB, et al
These treatments are typically used if you have severe inflammation or redness in the affected area
[PubMed Central ID: PMC9640911]
[Ref] Other Very common (10% or more): Pain (35%), flu syndrome (29%), chest pain (15%), accidental injury (12%), asthenia (12%), fever (12%) Common (1% to 10%): Peripheral edema, weight decrease, weight increase Very rare (less than 0.01%): Body odor, International Normalized Ratio (INR) increased [Ref] Local Very common (10% or more): Injection site reaction (38%) [Ref] Musculoskeletal Musculoskeletal side effects, in chronic hemodialysis patients, for levocarnitine (the active ingredient contained in L-Carnitine) in relation to placebo therapy have included asthenia (8% to 12% vs 8%) and leg cramps (4% to 8% vs 13%)
[6] Clinical evidence for skin The clinical data for GHK-Cu on human skin are real but limited in scope